Publications
(2026) An allosteric network governs Tom70 conformational dynamics to coordinate mitochondrial import. Structure. 34, 273-283.e6
(2026) Benzoxaborole-modified azithromycins inhibit translation without inducing expression. Antimicrob Agents Chemother. 10.1128/aac.01539-25
(2026) Benzoxaborole-modified azithromycins inhibit translation without inducing expression. Antimicrob Agents Chemother. 10.1128/aac.01539-25
(2026) Benzoxaborole-modified azithromycins inhibit translation without inducing expression. Antimicrob Agents Chemother. 10.1128/aac.01539-25
(2026) The CspC:CspA heterodimer transduces germinant and co-germinant signals during Clostridioides difficile spore germination. PLoS Biol. 24, e3003610
(2026) The CspC:CspA heterodimer transduces germinant and co-germinant signals during Clostridioides difficile spore germination. PLoS Biol. 24, e3003610
(2026) The CspC:CspA heterodimer transduces germinant and co-germinant signals during Clostridioides difficile spore germination. PLoS Biol. 24, e3003610
(2026) Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ.. ACS Med Chem Lett. 17, 433-440
(2026) Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ.. ACS Med Chem Lett. 17, 433-440
(2026) Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer. Eur J Med Chem. 311, 118798
(2026) Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer. Eur J Med Chem. 311, 118798
(2026) Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer. Eur J Med Chem. 311, 118798
(2026) Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. J Med Chem. 69, 5241-5258
(2026) Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. J Med Chem. 69, 5241-5258
(2026) Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. J Med Chem. 69, 5241-5258
(2026) Dual recruitment of two CCM2 molecules to KRIT1 suppresses KLF4 expression. Nat Commun. 10.1038/s41467-026-69595-7
(2026) Nucleotide signals coordinate activation and inhibition of bacterial immunity. Nature. 652, 978-985
(2026) Small-molecule binding and sensing with a designed protein family. Nat Commun. 10.1038/s41467-026-70953-8
(2026) Structure of SHOC2-KRAS-PP1C complex reveals RAS isoform-specific determinants and insights into targeting complex assembly by RAS inhibitors. Nat Commun. 10.1038/s41467-026-68319-1
(2026) Structure of SHOC2-KRAS-PP1C complex reveals RAS isoform-specific determinants and insights into targeting complex assembly by RAS inhibitors. Nat Commun. 10.1038/s41467-026-68319-1
(2026) Tetravalent antibodies are more potent and efficacious erythropoiesis-stimulating agents than erythropoietin in vivo. Protein Sci. 35, e70462
(2026) Tetravalent antibodies are more potent and efficacious erythropoiesis-stimulating agents than erythropoietin in vivo. Protein Sci. 35, e70462
(2025) Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domain. Eur J Med Chem. 302, 118274

